Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,581 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category.
Muchtar E, Dispenzieri A, Kumar SK, Ketterling RP, Dingli D, Lacy MQ, Buadi FK, Hayman SR, Kapoor P, Leung N, Chakraborty R, Gonsalves W, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Go RS, Zeldenrust S, Kyle RA, Rajkumar SV, Gertz MA. Muchtar E, et al. Among authors: chakraborty r. Leukemia. 2017 Jul;31(7):1562-1569. doi: 10.1038/leu.2016.369. Epub 2016 Dec 1. Leukemia. 2017. PMID: 27904139
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival.
Muchtar E, Dispenzieri A, Kumar SK, Buadi FK, Lacy MQ, Zeldenrust S, Hayman SR, Leung N, Kourelis TV, Gonsalves W, Chakraborty R, Russell S, Dingli D, Lust JA, Lin Y, Kapoor P, Go R, Kyle RA, Rajkumar SV, Gertz MA. Muchtar E, et al. Among authors: chakraborty r. Leukemia. 2017 Jan;31(1):92-99. doi: 10.1038/leu.2016.140. Epub 2016 May 23. Leukemia. 2017. PMID: 27211265
Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival.
Tandon N, Muchtar E, Sidana S, Dispenzieri A, Lacy MQ, Dingli D, Buadi FK, Hayman SR, Chakraborty R, Hogan WJ, Gonsalves W, Warsame R, Kourelis TV, Leung N, Kapoor P, Kumar SK, Gertz MA. Tandon N, et al. Among authors: chakraborty r. Bone Marrow Transplant. 2017 Aug;52(8):1126-1132. doi: 10.1038/bmt.2017.68. Epub 2017 Apr 10. Bone Marrow Transplant. 2017. PMID: 28394369
Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis.
Muchtar E, Dean DS, Dispenzieri A, Dingli D, Buadi FK, Lacy MQ, Hayman SR, Kapoor P, Leung N, Russell S, Lust JA, Lin Y, Warsame R, Gonsalves W, Kourelis TV, Go RS, Chakraborty R, Zeldenrust S, Kyle RA, Rajkumar SV, Kumar SK, Gertz MA. Muchtar E, et al. Among authors: chakraborty r. J Intern Med. 2017 Jun;281(6):611-619. doi: 10.1111/joim.12617. Epub 2017 Apr 24. J Intern Med. 2017. PMID: 28439924 Free article.
Autologous stem cell transplant for multiple myeloma patients 70 years or older.
Muchtar E, Dingli D, Kumar S, Buadi FK, Dispenzieri A, Hayman SR, Wolf RC, Gastineau DA, Chakraborty R, Hogan WJ, Leung N, Kapoor P, Lacy MQ, Rajkumar SV, Gertz MA. Muchtar E, et al. Among authors: chakraborty r. Bone Marrow Transplant. 2016 Nov;51(11):1449-1455. doi: 10.1038/bmt.2016.174. Epub 2016 Jul 4. Bone Marrow Transplant. 2016. PMID: 27376447
Lymphoplasmacytic lymphoma: What we need to know.
Chakraborty R, Gertz MA. Chakraborty R, et al. Leuk Lymphoma. 2016 May;57(5):991-2. doi: 10.3109/10428194.2015.1092531. Epub 2015 Oct 13. Leuk Lymphoma. 2016. PMID: 26374283 No abstract available.
1,581 results